Racial disparities in treatment-related cardiovascular toxicities amongst women with breast cancer: a scoping review
Purpose Black women often experience poorer breast cancer-related outcomes and higher
mortality than white women. A contributor to this disparity may relate to the disproportionate …
mortality than white women. A contributor to this disparity may relate to the disproportionate …
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897
PA Ganz, MA Hussey, CM Moinpour… - Journal of Clinical …, 2008 - ascopubs.org
Purpose The late cardiac effects of adjuvant anthracycline therapy in survivors of early-stage
breast cancer have had limited study. Subclinical and clinical cardiac late effects may …
breast cancer have had limited study. Subclinical and clinical cardiac late effects may …
[HTML][HTML] Value of information analysis of multiparameter tests for chemotherapy in early breast cancer: the OPTIMA prelim trial
Background Precision medicine is heralded as offering more effective treatments to smaller
targeted patient populations. In breast cancer, adjuvant chemotherapy is standard for …
targeted patient populations. In breast cancer, adjuvant chemotherapy is standard for …
The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines
G Dranitsaris, D Rayson, M Vincent, J Chang… - Breast cancer research …, 2008 - Springer
Background Cardiac toxicity from anthracyclines (ACH) can lead to therapy discontinuation,
hospitalization or congestive heart failure (CHF). Since such risk may vary by patient, we …
hospitalization or congestive heart failure (CHF). Since such risk may vary by patient, we …
Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients …
M Coutinho Cruz, L Moura Branco, G Portugal… - Clinical Research in …, 2020 - Springer
Abstract Background Assessment of 2D/3D left ventricular ejection fraction (LVEF) and 2D
global longitudinal strain (GLS) is the gold standard for diagnosing cancer therapeutics …
global longitudinal strain (GLS) is the gold standard for diagnosing cancer therapeutics …
Cardiac outcomes in survivors of pediatric and adult cancers
More than 80% of children and 60% of adults with cancer will become long-term survivors,
emphasizing the importance of late effects of cancer therapy. Cardiotoxicity due to …
emphasizing the importance of late effects of cancer therapy. Cardiotoxicity due to …
[HTML][HTML] Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
Background/aim Cardiotoxicity is a potential complication of anticancer therapy. While
guidelines have been developed to assist practitioners, an effective, evidence based clinical …
guidelines have been developed to assist practitioners, an effective, evidence based clinical …
[HTML][HTML] Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil-or epirubicin-based …
Background Epirubicin-based chemotherapy improves the outcome of early breast cancer
(BC) patients. However, cardiotoxicity remains an important side effect. Methods We re …
(BC) patients. However, cardiotoxicity remains an important side effect. Methods We re …
Anthracycline cardiotoxicity after breast cancer treatment
DL Hershman, T Shao - Oncology, 2009 - go.gale.com
Anthracyclines are among the most active agents for the treatment of breast cancer; their use
in combination regimens improves both disease-free and overall survival in patients with …
in combination regimens improves both disease-free and overall survival in patients with …
[HTML][HTML] Cardio-Oncology rehabilitation-challenges and opportunities to improve cardiovascular outcomes in cancer patients and survivors
While the number of cancer patients is increasing with the arrival of the super-aging society,
the age-adjusted mortality rate of cancer decreases due to medical advances, and the …
the age-adjusted mortality rate of cancer decreases due to medical advances, and the …